NSE: AMIORG | BSE: 543349

Expensive Performer

Download real time

1148.00 -54.10 (-4.50%)

127.78% Gain from 52W Low

472.0K NSE+BSE Volume

NSE 06 May, 2025 1:47 PM (IST)

9,398.5

Market Cap

Above industry Median

1.5

Beta 1Year

Very High Volatility

Ami Organics Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for AMIORG, BSE:543349 Ami Organics Ltd.

Search Inside the pdf :

Ami Organics Ltd.

29 Jan 2025

1148.00

-4.50%

Late stage CDMO projects to be key growth catalyst

Buy: Ami Organics Ltd.

Recommendation Target

KRChoksey

Ami Organics’ revenue beat our estimates significantly due to strong growth in Advanced Intermediates segment. EBITDA and Adj. PAT was well above our estimates due to better-than-expected gross profit and operating leverage.

Ami Organics Ltd. is trading below its 30 day SMA of 1158.6

Ami Organics Ltd.

30 Oct 2024

1148.00

-4.50%

Ami Organics: Q2FY25 Result Review

Buy: Ami Organics Ltd.

Recommendation Target

IDBI Capital

Ami Organics Ltd. has gained 92.75% in the last 1 Year

Ami Organics Ltd.

30 Oct 2024

1148.00

-4.50%

Outlook remains strong with robust top-line growth and margin expansion

Accumulate: Ami Organics Ltd.

Target

KRChoksey

Ami Organics’ revenue beat our estimates significantly due to strong growth in Advanced Intermediates. This is reflected in EBITDA and Adj. PAT performance, which beat our estimates primarily due to lower-than-expected employee expenses.

Number of FII/FPI investors increased from 125 to 154 in Mar 2025 qtr.

Ami Organics Ltd.

21 Aug 2024

1148.00

-4.50%

Demand pickup in Advanced Intermediates segment will drive revenue growth

Accumulate: Ami Organics Ltd.

Target

KRChoksey

Ami Organics’ revenue missed our estimates due to a decline in price realization. EBITDA missed our estimates due to an increase in raw material costs and employee expenses.

Ami Organics Ltd. has gained 92.75% in the last 1 Year

Ami Organics Ltd.

16 May 2024

1148.00

-4.50%

Continued improved utilisation to drive growth

Accumulate: Ami Organics Ltd.

Target

KRChoksey

Ami Organics’ revenue beat our estimate by 2.3% due to strong volume growths across both Advanced Intermediates and Specialty chemicals segments. The EBITDA beat our estimates by a strong 32.5% due to much lower operating expenses.

Ami Organics Ltd. is trading above its 200 day SMA of 964.3

Ami Organics Ltd.

14 May 2024

1148.00

-4.50%

Ami Organics: Q4FY24 Result Review

Hold: Ami Organics Ltd.

Target

IDBI Capital

Ami Organics Ltd.'s price crossed below 30Day SMA today

Ami Organics Ltd.

19 Feb 2024

1148.00

-4.50%

Multiple products expected to drive growth in FY25E

Accumulate: Ami Organics Ltd.

Target

KRChoksey

For Q3FY24, Ami Organics revenue increased 9.2% YoY (-3.4% QoQ) to INR 1,664 Mn. For 9MFY24, the revenue increased by 14.4% YoY to INR 4,925 Mn.

Ami Organics Ltd. is trading above its 200 day SMA of 964.3

Ami Organics Ltd.

13 Feb 2024

1148.00

-4.50%

Ami Organics: Q3FY24 Result Review

Hold: Ami Organics Ltd.

Recommendation Target

IDBI Capital

Ami Organics Ltd. is trading below its 30 day SMA of 1158.6

Ami Organics Ltd.

23 Nov 2023

1148.00

-4.50%

Delayed launches and increased hiring impact the margins

Accumulate: Ami Organics Ltd.

Recommendation Target

KRChoksey

In Q2FY24, the Specialty chemicals segment witnessed revenue growth of 71.4% YoY to INR 378 Mn. The Advance Intermediates (API) segment reported an increase of 7.7% YoY to INR 1,346 Mn. The advanced intermediates segment continued to see pricing pressure that impacted sales growth in Q2FY24.